Feb 05,2026 Galaxy Brain Scientific’s Technology Enables Landmark Parkinson’s Study Published in Nature, Redefining Disease Mechanism read more >>
Jan 05,2026 Lysoway Therapeutics Announces Phase I Readiness of Brain-Penetrant TRPML1 Agonist LW-1017 and Nomination of a TMEM175 Development Candidate read more >>
Oct 16,2025 Lysoway showcases first-in-class TRPML1 agonist data and announces Phase I clinical plan at Michael J. Fox foundation’s PD Therapeutics Conference read more >>
Oct 06,2025 Lipidio Pharmaceuticals Expands Advisory Team with Appointment of Renowned Experts Arne Astrup, MD and Mark Lappe read more >>
Apr 15,2025 ProNovo Closes Seed Financing Round to Advance Multiple Preclinical Programs read more >>
Jul 07,2025 Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD) read more >>
Feb 28,2023 Aravive Announces FDA Orphan Drug Designation Granted to Batiraxcept for the Treatment of Pancreatic Cancer read more >>